Source: Eur Respir J, 52 (1) 1800475; 10.1183/13993003.00475-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nicholas T. Vozoris, Xuesong Wang, Peter C. Austin, Anne L. Stephenson, Denis E. O'Donnell, Andrea S. Gershon, Sudeep S. Gill, Paula A. Rochon. Serotonergic antidepressant use and morbidity and mortality among older adults with COPD. Eur Respir J, 52 (1) 1800475; 10.1183/13993003.00475-2018

Member's Comments

No comment yet.

Related content which might interest you: Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2014; 44: 332-340 Year: 2014 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 566-567 Year: 2015 Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2015; 45: 565-566 Year: 2015 Incident opioid drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J , 49 (3) 1602311; DOI: 10.1183/13993003.02311-2016 Year: 2017 Incident opioid drug use and adverse respiratory outcomes among older adults with COPD Source: Eur Respir J 2016; 48: 683-693 Year: 2016 Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics Source: Eur Respir J 2001; 17: 380-385 Year: 2001 Excess morbidity and mortality in patients with asthma on long-acting beta2-agonists Source: Annual Congress 2007 - Effect of long acting beta-agonists on severe asthma exacerbations and asthma-related deaths Year: 2007 Predictors of mortality in COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Predictors of mortality in COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study Source: ERJ Open Res, 8 (1) 00628-2021; 10.1183/23120541.00628-2021 Year: 2022 No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Excess mortality in patients with asthma on long-acting β2-agonists Source: Eur Respir J 2006; 28: 900-902 Year: 2006 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Mean nocturnal respiratory rate predicts cardiovascular and all-cause mortality in community-dwelling older men and women Source: Eur Respir J, 54 (1) 1802175; 10.1183/13993003.02175-2018 Year: 2019 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Association of symptom subtypes and obstructive sleep apnoea-specific hypoxic burden with cardiovascular morbidity and all-cause mortality Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021 Long-term impact of COPD on postoperative cardiorespiratory morbidity and mortality: a population cohort study Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 Prevalence of comorbidity in patients with COPD and its effect on mortality Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003